# Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer

> **NCT01718626** · PHASE2 · UNKNOWN · sponsor: **Hebei Tumor Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S1+Docetaxel
- **DRUG:** S1+Docetaxel followed by S1

## Key facts

- **NCT ID:** NCT01718626
- **Lead sponsor:** Hebei Tumor Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718626, "Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01718626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*